Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

[Accumulation Characteristics and Health Risk Assessment of Heavy Metals in Wild Fish Species from Diaojiang River, Guangxi].

Wang JN, Ma PC, Zhang LJ, Chen MB, Huang CS, Liu XL, Hu GC, Xu ZC.

Huan Jing Ke Xue. 2017 Jun 8;38(6):2600-2606. doi: 10.13227/j.hjkx.201611188. Chinese.

PMID:
29965383
2.

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM.

N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.

PMID:
29466156
3.

Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura.

Boothe JT, Budd GT, Smolkin MB, Ma PC.

Case Rep Oncol. 2017 Nov 13;10(3):998-1005. doi: 10.1159/000484041. eCollection 2017 Sep-Dec.

4.

Three-dimensional titanium dioxide/graphene hybrids with improved performance for photocatalysis and energy storage.

Chen L, Yang S, Mu L, Ma PC.

J Colloid Interface Sci. 2018 Feb 15;512:647-656. doi: 10.1016/j.jcis.2017.10.103. Epub 2017 Oct 28.

PMID:
29102911
5.

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.

Oronsky B, Ma PC, Morgensztern D, Carter CA.

Neoplasia. 2017 Dec;19(12):991-1002. doi: 10.1016/j.neo.2017.09.002. Epub 2017 Nov 5. Review.

6.

Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.

Pilotto S, Carbognin L, Karachaliou N, Ma PC, Rosell R, Tortora G, Bria E.

Cancer Treat Rev. 2017 Nov;60:1-11. doi: 10.1016/j.ctrv.2017.08.002. Epub 2017 Aug 20. Review.

PMID:
28843992
7.

Surface roughness induced superhydrophobicity of graphene foam for oil-water separation.

Yang S, Chen L, Wang C, Rana M, Ma PC.

J Colloid Interface Sci. 2017 Dec 15;508:254-262. doi: 10.1016/j.jcis.2017.08.061. Epub 2017 Aug 18.

PMID:
28843104
8.

YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.

Guo T, Zhao S, Wang P, Xue X, Zhang Y, Yang M, Li N, Li Z, Xu L, Jiang L, Zhao L, Ma PC, Rosell R, Li J, Gu C.

Oncotarget. 2017 Jul 18;8(29):48110-48125. doi: 10.18632/oncotarget.18262.

9.

Widom Lines in Binary Mixtures of Supercritical Fluids.

Raju M, Banuti DT, Ma PC, Ihme M.

Sci Rep. 2017 Jun 8;7(1):3027. doi: 10.1038/s41598-017-03334-3.

10.

AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.

Wu X, Ma W, Zhou Q, Yan H, Lim ZF, Huang M, Deng C, Yu X, Su H, Komo S, Yang H, Zhang X, Wen S, Zhang Z, Ma PC.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1947-1957. doi: 10.1007/s00432-017-2408-4. Epub 2017 May 27.

11.

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

Chaib I, Karachaliou N, Pilotto S, Codony Servat J, Cai X, Li X, Drozdowskyj A, Servat CC, Yang J, Hu C, Cardona AF, Vivanco GL, Vergnenegre A, Sanchez JM, Provencio M, de Marinis F, Passaro A, Carcereny E, Reguart N, Campelo CG, Teixido C, Sperduti I, Rodriguez S, Lazzari C, Verlicchi A, de Aguirre I, Queralt C, Wei J, Estrada R, Puig de la Bellacasa R, Ramirez JL, Jacobson K, Ditzel HJ, Santarpia M, Viteri S, Molina MA, Zhou C, Cao P, Ma PC, Bivona TG, Rosell R.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx014.

12.

Special issue: "MET as actionable target in cancer therapy".

Ma PC.

Ann Transl Med. 2017 Jan;5(1):1. doi: 10.21037/atm.2017.01.10. No abstract available.

13.

Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.

Thiagarajan PS, Wu X, Zhang W, Shi I, Bagai R, Leahy P, Feng Y, Veigl M, Lindner D, Danielpour D, Yin L, Rosell R, Bivona TG, Zhang Z, Ma PC.

Oncotarget. 2016 Dec 13;7(50):82013-82027. doi: 10.18632/oncotarget.13307.

14.

Inhibition of YAP/TAZ Activity in Spinal Cord Suppresses Neuropathic Pain.

Xu N, Wu MZ, Deng XT, Ma PC, Li ZH, Liang L, Xia MF, Cui D, He DD, Zong Y, Xie Z, Song XJ.

J Neurosci. 2016 Sep 28;36(39):10128-40. doi: 10.1523/JNEUROSCI.0800-16.2016. Epub 2016 Sep 28.

15.

Activation of ephrinB-EphB receptor signalling in rat spinal cord contributes to maintenance of diabetic neuropathic pain.

Deng XT, Wu MZ, Xu N, Ma PC, Song XJ.

Eur J Pain. 2017 Feb;21(2):278-288. doi: 10.1002/ejp.922. Epub 2016 Jul 27.

PMID:
27461472
16.

Simultaneous quantification of chlorogenic acid and taurocholic acid in human plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Shuanghua Baihe tablets.

Gu P, Liu RJ, Cheng ML, Wu Y, Zheng L, Liu YJ, Ma PC, Ding L.

Chin J Nat Med. 2016 Apr;14(4):313-320. doi: 10.1016/S1875-5364(16)30034-6.

PMID:
27114321
17.

Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.

Hembrough T, Liao WL, Hartley CP, Ma PC, Velcheti V, Lanigan C, Thyparambil S, An E, Monga M, Krizman D, Burrows J, Tafe LJ.

Clin Chem. 2016 Jan;62(1):252-61. doi: 10.1373/clinchem.2015.245860. Epub 2015 Nov 19.

18.

Wnt/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats.

Liu S, Liu YP, Huang ZJ, Zhang YK, Song AA, Ma PC, Song XJ.

Pain. 2015 Dec;156(12):2572-84. doi: 10.1097/j.pain.0000000000000366.

PMID:
26407042
19.

MET receptor juxtamembrane exon 14 alternative spliced variant: novel cancer genomic predictive biomarker.

Ma PC.

Cancer Discov. 2015 Aug;5(8):802-5. doi: 10.1158/2159-8290.CD-15-0769.

20.

RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib.

Mukhopadhyay S, Pennell NA, Ali SM, Ross JS, Ma PC, Velcheti V.

J Thorac Oncol. 2014 Nov;9(11):1714-9. doi: 10.1097/JTO.0000000000000323.

21.

Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib.

Agwa ES, Ma PC.

Cancer Manag Res. 2014 Oct 4;6:397-404. doi: 10.2147/CMAR.S37345. eCollection 2014. Review.

22.

EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).

Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC.

Lung Cancer. 2014 Nov;86(2):158-63. doi: 10.1016/j.lungcan.2014.09.003. Epub 2014 Sep 22.

PMID:
25263855
23.

Acquired trichomegaly: trichomegaly secondary to erlotinib.

Medina Mendez CA, Ma PC, Singh AD.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545. No abstract available.

PMID:
25078467
24.

Controlled synthesis of hierarchical TiO2 nanoparticles on glass fibres and their photocatalytic performance.

Chen L, Yang S, Mäder E, Ma PC.

Dalton Trans. 2014 Sep 7;43(33):12743-53. doi: 10.1039/c4dt00977k.

PMID:
25011616
25.

Magnetic graphene foam for efficient adsorption of oil and organic solvents.

Yang S, Chen L, Mu L, Ma PC.

J Colloid Interface Sci. 2014 Sep 15;430:337-44. doi: 10.1016/j.jcis.2014.05.062. Epub 2014 Jun 9.

PMID:
24974246
26.

ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.

Minca EC, Lanigan CP, Reynolds JP, Wang Z, Ma PC, Cicenia J, Almeida FA, Pennell NA, Tubbs RR.

J Thorac Oncol. 2014 Apr;9(4):464-8. doi: 10.1097/JTO.0000000000000104.

27.

High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer.

Feng Y, Minca EC, Lanigan C, Liu A, Zhang W, Yin L, Pennell NA, Farver C, Tubbs R, Ma PC.

J Thorac Oncol. 2014 May;9(5):646-53. doi: 10.1097/JTO.0000000000000145.

28.

Microwave field controlled slow and fast light with a coupled system consisting of a nanomechanical resonator and a Cooper-pair box.

Ma PC, Xiao Y, Yu YF, Zhang ZM.

Opt Express. 2014 Feb 10;22(3):3621-8. doi: 10.1364/OE.22.003621.

PMID:
24663653
29.

All-trans retinoic acid induces cell-cycle arrest in human cutaneous squamous carcinoma cells by inhibiting the mitogen-activated protein kinase-activated protein 1 pathway.

Zhang ML, Tao Y, Zhou WQ, Ma PC, Cao YP, He CD, Wei J, Li LJ.

Clin Exp Dermatol. 2014 Apr;39(3):354-60. doi: 10.1111/ced.12227.

PMID:
24635079
30.

Choroidal metastases responsive to crizotinib therapy in a lung adenocarcinoma patient with ALK 2p23 fusion identified by ALK immunohistochemistry.

Feng Y, Singh AD, Lanigan C, Tubbs RR, Ma PC.

J Thorac Oncol. 2013 Dec;8(12):e109-11. doi: 10.1097/01.JTO.0000437502.82078.9b. No abstract available.

31.

Development of carbon nanotubes/CoFe2O4 magnetic hybrid material for removal of tetrabromobisphenol A and Pb(II).

Zhou L, Ji L, Ma PC, Shao Y, Zhang H, Gao W, Li Y.

J Hazard Mater. 2014 Jan 30;265:104-14. doi: 10.1016/j.jhazmat.2013.11.058. Epub 2013 Dec 4.

PMID:
24342050
32.

Overview of various techniques/platforms with critical evaluation of each.

Agwa E, Ma PC.

Curr Treat Options Oncol. 2013 Dec;14(4):623-33. doi: 10.1007/s11864-013-0259-z. Review.

PMID:
24243164
33.

ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.

Minca EC, Portier BP, Wang Z, Lanigan C, Farver CF, Feng Y, Ma PC, Arrossi VA, Pennell NA, Tubbs RR.

J Mol Diagn. 2013 May;15(3):341-6. doi: 10.1016/j.jmoldx.2013.01.004. Epub 2013 Mar 13.

PMID:
23499337
34.

Cancer genes in lung cancer: racial disparities: are there any?

El-Telbany A, Ma PC.

Genes Cancer. 2012 Jul;3(7-8):467-80. doi: 10.1177/1947601912465177.

35.

Combined treatment with MET inhibitors and other therapies in lung cancer.

Bagai R, Ma PC.

Transl Lung Cancer Res. 2012 Sep;1(3):214-8. doi: 10.3978/j.issn.2218-6751.2012.09.07. No abstract available.

36.

MET targeted therapy for lung cancer: clinical development and future directions.

Feng Y, Ma PC.

Lung Cancer (Auckl). 2012 Aug 9;3:53-67. doi: 10.2147/LCTT.S23423. eCollection 2012. Review.

37.

Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.

Tao Y, Zhang ML, Ma PC, Sun JF, Zhou WQ, Cao YP, Li LJ.

Asian Pac J Cancer Prev. 2012;13(4):1611-5.

38.

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG.

Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330.

39.

Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib.

Pennell NA, Yin L, Keshtgarpour M, Ma PC.

J Thorac Oncol. 2012 Jul;7(7):1200-1. doi: 10.1097/JTO.0b013e318250ed89. No abstract available.

40.

Personalized targeted therapy in advanced non-small cell lung cancer.

Ma PC.

Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS56-60. doi: 10.3949/ccjm.79.s2.12. Review.

PMID:
22614968
41.

Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.

Feng Y, Ma PC.

Cancer Discov. 2011 Dec;1(7):550-4. doi: 10.1158/2159-8290.CD-11-0289.

42.

Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer.

Schwandt A, Mekhail T, Halmos B, O'Brien T, Ma PC, Fu P, Ivy P, Dowlati A.

J Thorac Oncol. 2012 Apr;7(4):751-4. doi: 10.1097/JTO.0b013e31824abca2.

43.

Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients.

Fu P, Panneerselvam A, Clifford B, Dowlati A, Ma PC, Zeng G, Halmos B, Leidner RS.

Stat Methods Med Res. 2015 Dec;24(6):937-48. doi: 10.1177/0962280211434179. Epub 2012 Jan 12.

PMID:
22246415
44.

MET signaling: novel targeted inhibition and its clinical development in lung cancer.

Feng Y, Thiagarajan PS, Ma PC.

J Thorac Oncol. 2012 Feb;7(2):459-67. doi: 10.1097/JTO.0b013e3182417e44. Review.

45.

Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.

Su MX, Liu MH, Di B, Huang LL, Jiang Y, Ma PC, Hang TJ.

Eur J Drug Metab Pharmacokinet. 2011 Dec;36(4):223-8. doi: 10.1007/s13318-011-0064-7. Epub 2011 Sep 14.

PMID:
21915733
46.

Evaluation of the skin sensitization potential of chemicals in THP-1/keratinocyte co-cultures.

Cao YP, Ma PC, Liu WD, Zhou WQ, Tao Y, Zhang ML, Li LJ, Chen ZY.

Immunopharmacol Immunotoxicol. 2012 Apr;34(2):196-204. doi: 10.3109/08923973.2011.591800. Epub 2011 Jul 1.

PMID:
21721923
47.

MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents.

Fan W, Tang Z, Yin L, Morrison B, Hafez-Khayyata S, Fu P, Huang H, Bagai R, Jiang S, Kresak A, Howell S, Vasanji A, Flask CA, Halmos B, Koon H, Ma PC.

Cancer Res. 2011 Jul 1;71(13):4494-505. doi: 10.1158/0008-5472.CAN-10-2668. Epub 2011 May 9.

48.

[Effect of cadmium oxide in air of workplace on lens].

Ma PC.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Dec;28(12):908. Chinese. No abstract available.

PMID:
21241600
49.

Hydrothermal synthesis of layered sodium manganese oxide nanowires and their electrochemical performance.

Liu XM, Huang ZD, Oh SW, Ma PC, Ma J, Li BH, Kim JK.

J Nanosci Nanotechnol. 2010 Nov;10(11):7378-81.

PMID:
21137939
50.

Bell palsy and preeclampsia superimposed on chronic hypertension.

Juan YC, Au HK, Hsu JJ, Ma PC, Liu WM, Jeng CJ.

Taiwan J Obstet Gynecol. 2010 Jun;49(2):223-4. doi: 10.1016/S1028-4559(10)60049-6. No abstract available.

Supplemental Content

Support Center